Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis (ReAct)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00448383
Recruitment Status : Completed
First Posted : March 16, 2007
Last Update Posted : August 4, 2008
Information provided by: